Gabapentin Capsule
Product Images NDC 80425-0079

8 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1

Figure 1
Line graph depicting mean pain score over 8 weeks during a study with a 4-week dose titration period followed by a 4-week fixed dose period. The graph compares placebo and Gabapentin at 3,600 mg/day dosages, showing pain score trends from baseline through weeks 1 to 8.*
FDA Label Image

Figure 2

Figure 2
A line graph depicting mean pain scores over a 7-week period including a 3-week dose titration and a 4-week fixed dose period. It compares placebo and two dosages of Gabapentin (1,800 mg/day and 2,400 mg/day) with values marked at baseline and weekly intervals.*
FDA Label Image

Figure 3

Figure 3
A bar chart comparing percentages between placebo (PBO) and Gabapentin (GBP) at various doses in two studies. Study 1 shows 12% for PBO and 29% for GBP 3,600 mg. Study 2 displays 14% for PBO, 32% for GBP 1,800 mg, and 34% for GBP 2,400 mg. Statistical significance is noted with p-values less than 0.01 and 0.001.*
FDA Label Image

Figure 4

Figure 4
A bar graph depicting percentage differences related to daily doses of gabapentin in milligrams (600, 900, 1200, 1800 mg) across three studies labeled a, b, and c. The graph uses different colored squares to represent each study and plots the percentage difference on the vertical axis.*
FDA Label Image

Gabapentin 300mg Cap Qty 30 Ndc 80425 0079

Gabapentin 300mg Cap Qty 30 Ndc 80425 0079
Gabapentin 300 mg oral capsules, packaged in a container of 30 capsules by Advanced Rx of Tennessee, LLC. The label includes the NDC code 80425-0079, lot number 30PG00423, and expiration date 4/30/2023. Storage instructions specify room temperature between 20°-25°C (68°-77°F).*
FDA Label Image

Gabapentin 300mg Cap Qty 60 Ndc 80425 0079

Gabapentin 300mg Cap Qty 60 Ndc 80425 0079
Gabapentin 300 mg capsules in a pack of 60 by Advanced Rx of Tennessee, LLC. The label includes storage instructions and a caution about federal law prohibiting removal of the drug by unauthorized persons. The label also features the Advanced Rx logo and a QR code.*
FDA Label Image

Gabapentin 300mg Cap Qty 90 Ndc 80425 0079

Gabapentin 300mg Cap Qty 90 Ndc 80425 0079
Gabapentin 300 mg capsule carton label from Advanced Rx of Tennessee, LLC. The label shows the proprietary name Gabapentin, strength 300 mg, package size of 90 capsules, and includes the product NDC 80425-0079. It also features storage instructions, lot number, expiration date, and a barcode.*
FDA Label Image

Structure

Structure
Chemical structure of Gabapentin showing a cyclohexane ring with attached amino (CH2NH2) and carboxymethyl (CH2CO2H) groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.